Show Latest Posts:

The 10 Most Recent Messages By TMFBiologyFool

Take me back to where I was.
  • Date: 9/19/11 1:07 PM
  • Number: 729
  • Recommendations: 8
http://online.wsj.com/article/SB1000142405311190337400457658...
Amphastar Pharmaceuticals Inc. said it received notification Monday morning that its
(Continued...)
  • Date: 12/22/10 4:23 PM
  • Number: 815
  • Recommendations: 2
There are still two arms of VX-222 (at two doses) + telaprevir + standard of care (Pegasys + Copegus/ribavirin) and an all oral arm of VX-222 (at the low dose) + telaprevir + Copegus/ribavirin.

That should read at the
(Continued...)
  • Date: 12/22/10 4:17 PM
  • Number: 814
  • Recommendations: 1
Revisiting this thread because Vertex just announced today that the higher dose failed as well.
(Continued...)
  • Date: 11/18/10 7:01 PM
  • Number: 817
  • Recommendations: 2
I would like to know what's the likely outcome in a situation like this: staff -> NO, panel review -> OK

Examples:
(Continued...)
  • Date: 11/18/10 5:45 PM
  • Number: 806
  • Recommendations: 1
5:31 adam feuerstein: wow!

That's an understatement. I'm a bit surprised it was that positive, but as I said yesterday, a mildly positive vote is about the best investors could have hoped for.

Now let's see if investors
(Continued...)
  • Date: 11/18/10 4:16 PM
  • Number: 543
  • Recommendations: 5
Oops, should have copied over the next paragraph too:
After all the expenses for making and selling the drug were taken care of, Momenta's share of the profits came out to $44 million. But -- and this is a big but -- Momenta was required to
(Continued...)
  • Date: 11/18/10 4:15 PM
  • Number: 542
  • Recommendations: 0
My back of the envelope calculations including that extra $35 million:
http://www.fool.com/investing/high-growth/2010/11/01/momenta...
After
(Continued...)
  • Date: 11/17/10 2:12 PM
  • Number: 780
  • Recommendations: 0
I wouldn't draw too much hope from the Benlysta advisory committee. Benlysta meets an unmet need (there hasn't been a new lupus treatment in 50+ years). I don't think you can say the same thing about MELAFind. I have a hard time seeing the panel
(Continued...)
  • Date: 11/4/10 3:52 PM
  • Number: 536
  • Recommendations: 1
I believe the trial is supposed to start in May of 2011 for Copaxone. That will be the real breadwinning, cash cow for Momenta, without a doubt. And no one else has submitted an ANDA for it yet either.

Mylan has submitted an ANDA for
(Continued...)
  • Date: 11/1/10 6:23 PM
  • Number: 521
  • Recommendations: 6
5! Five! Fünf!

It's not hard to get there; it just might be hard to stay.
(Continued...)
Show Latest Posts:
Total = 10

Take me back to where I was.
Stock Folders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z